Screening for the Diagnosis of Diabetic Peripheral Neuropathy in Type-2 Diabetes Mellitus in Southwest Iran

Baharvand, Parastoo; Hormozi, Maryam

doi:10.22087/ijac.2023.484706.1026

Screening for the Diagnosis of Diabetic Peripheral Neuropathy in Type-2 Diabetes Mellitus in Southwest Iran

Document Type : Research

Authors

Parastoo Baharvand ¹

Maryam Hormozi ²

¹ Social Determinants of Health Research Center, Faculty of Medicine. Lorestan University of Medical Science, Khorramabad, Iran

² Razi Herbal Medicines Research Center, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran

10.22087/ijac.2023.484706.1026

Abstract

Background: Diabetic Peripheral Neuropathy (DPN) is a major debilitating complication in patients with diabetes. Evidence suggests that the early screening diagnosis of neuropathy can reduce the risk of diabetic foot ulcers and amputations.
Objectives: The present study was conducted to screen peripheral neuropathy in type-2 diabetes mellitus.
Methods: This cross-sectional study was conducted on 200 patients with type-2 diabetes mellitus who were randomly
Diabetic Peripheral Neuropathy is a major debilitating complication in patients with diabetes. Evidence suggests that the early screening diagnosis of neuropathy can reduce the risk of diabetic foot ulcers and amputations. The present study was conducted to screen peripheral neuropathy in type-2 diabetes mellitus. This cross-sectional study was conducted on 200 patients with type-2 diabetes mellitus randomly recruited from a diabetes center in Khorrambad, Iran, in 2020. DPN was assessed using the Michigan Neuropathy Screening Instrument in two parts: interviews about neuropathic symptoms and clinical examinations. The validity and reliability of the tool have already been confirmed.Two hundred patients (110 men, 90 women) with type-2 diabetes mellitus were studied. A total of 57 (27%) of them had Diabetic Peripheral Neuropathy. The duration of the disease [OR: 4.01; 95% CI (2.1-5.2)], age [OR: 1.3; 95% CI (1.4-3.5)], BMI [OR: 3.1; 95% CI (1.5-5.7)] and smoking [OR: 2.8; 95% CI (1.8-4.9)] were the main risk factors that had significant positive correlations with neuropathy (P<0.05). The present findings emphasize the importance of screening for the early diagnosis of neuropathy in patients with diabetes. Foot examination is recommended to be incorporated into the routine management of diabetic patients in primary care centers.

Keywords

Diabetes

Peripheral neuropathy

Screening

1. Wu S, Armstrong DG. Risk assessment of the diabetic foot and wound. International wound journal. 2005 Mar;2(1):17-24.
2. Vinik AL. Epidemiology of the complications of diabetes. Clin. Sci. Pract.. 1995:221-87.
3. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes care. 2005 Apr 1;28(4):956-62.
4. Lavery LA, Wunderlich RP, Tredwell JL. Disease management for the diabetic foot: effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations. Diabetes research and clinical practice. 2005 Oct 1;70(1):31-7.
5. Won JC, Kwon HS, Kim CH, Lee JH, Park TS, Ko KS, Cha BY. Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with type 2 diabetes in Korea. Diabetic Medicine. 2012 Sep;29(9):e290-6.
6. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes care. 2000 May 1;23(5):606-11.
7. Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian First Nation community. Diabetes care. 2008 Sep 1;31(9):1837-41.
8. Cabezas-Cerrato J, Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Diabetologia. 1998 Oct;41(11):1263-9.
9. DCCT Research Group. Factors in development of diabetic neuropathy: baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes. 1988 Apr 1;37(4):476-81.
10. Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clinical neurology and neurosurgery. 2006 Jul 1;108(5):477-81.
11. Janghorbani M, Rezvanian H, Kachooei A, Ghorbani A, Chitsaz A, Izadi F, Amini M. Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors. International Journal of Diabetes and Metabolism. 2006 Mar;14(3):126-33.
12. Tabatabaei-Malazy O, Mohajeri-Tehrani MR, Madani SP, Heshmat R, Larijani B. The prevalence of diabetic peripheral neuropathy and related factors. Iranian journal of public health. 2011 Sep 30;40(3):55.
13. RAHIMDEL AG, AFKHAMI AM, Souzani A, MODARESI M, Mashahiri MR. Prevalence of sensory neuropathy in type 2 diabetic patients in Iranian population (Yazd province).
14. Kiani J, Moghimbeigi A, Azizkhani H, Kosarifard S. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran. Archives of Iranian medicine. 2013 Jan 1;16(1):0-.
15. Survey Instrument. michigan diabetes research and training center, 2011 [cited 2013]. Available from: http://www.med.umich.edu/mdrtc/profs/survey.html.
16. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes care. 1994 Nov 1;17(11):1281-9.
17. Franse LV, Valk GD, Dekker JH, Heine RJ, Van Eijk JT. ‘Numbness of the feet’is a poor indicator for polyneuropathy in Type 2 diabetic patients. Diabetic medicine. 2000 Feb;17(2):105-10.
18. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The lancet. 1998 Sep 12;352(9131):837-53.
19. Al-Mahroos F, Al-Roomi K. Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients with diabetes in Bahrain: a nationwide primary care diabetes clinic-based study. Annals of Saudi medicine. 2007 Jan;27(1):25-31.
20. Eliasson B. Cigarette smoking and diabetes. Progress in cardiovascular diseases. 2003 Apr 1;45(5):405-13.
21. Karamifar H, Mooadab MH, Karamizadeh Z, Amirhakimi GH. Evaluation of peripheral neuropathy in patients with type 1 diabetes mellitus by bedside scoring procedure.
22. Zenere BM, Arcaro G, Saggiani F, Rossi L, Muggeo M, Lechi A. Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria. Diabetes Care. 1995 Jul 1;18(7):975-82.